Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Prostate Cancer Metastatic × Hematologic Tests × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Neoplasm Metastasis 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Colonic Neoplasms 2 Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer 1 Testicular Germ Cell Tumor 1 Stomach Neoplasms 1 Prostate Cancer Metastatic 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Obesity 1 Non-alcoholic Fatty Liver Disease 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Motor Activity 1 Metabolic Syndrome 1 Memory Disorders 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Liver Cirrhosis 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Hodgkin Disease 1 Heart Diseases 1 HPV Positive Oropharyngeal Squamous Cell Carcinoma 1 Cognitive Dysfunction 1 Brain Neoplasms 1

Interventions

enzalutamide 4 cabazitaxel 4 Prednisone 4 XRP6258 2 Docetaxel 2 sipuleucel-T 1 rucaparib 1 olaparib 1 Zuclomiphene 1 Prednisolone 1 Lenograstim 1 LY3023414 1 Injections 1 Hematologic Tests 1 Granulocyte Colony-Stimulating Factor 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03223727 2023-04-18

ROTOR

The Netherlands Cancer Institute

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡